健进制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
12
NMPA:12
Drug Approvals
Azacitidine for Injection
- Product Name
- 注射用阿扎胞苷
- Approval Number
- 国药准字H20244451
- Approval Date
- Jul 16, 2024
NMPA
Bortezomib for Injection
- Product Name
- 注射用硼替佐米
- Approval Number
- 国药准字H20243569
- Approval Date
- Apr 24, 2024
NMPA
Gemcitabine Hydrochloride for Injection
- Product Name
- 注射用盐酸吉西他滨
- Approval Number
- 国药准字H20233419
- Approval Date
- Apr 4, 2023
NMPA
Gemcitabine Hydrochloride for Injection
- Product Name
- 注射用盐酸吉西他滨
- Approval Number
- 国药准字H20233420
- Approval Date
- Apr 4, 2023
NMPA
Mycophenolate Mofetil for Injection
- Product Name
- 注射用吗替麦考酚酯
- Approval Number
- 国药准字H20223317
- Approval Date
- May 18, 2022
NMPA
Calcium Levofolinate for Injection
- Product Name
- 注射用左亚叶酸钙
- Approval Number
- 国药准字H20213965
- Approval Date
- Dec 31, 2021
NMPA
Bendamustine Hydrochloride for Injection
- Product Name
- 注射用盐酸苯达莫司汀
- Approval Number
- 国药准字H20213020
- Approval Date
- Jan 12, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found